The Technology Transfer team facilitates the commercialisation of UWE Intellectual Property. Our current opportunities reflect the many research strengths of UWE.
UWE technologies portfolio
Please use the links below for further details of technologies available for licensing:
- Foetal erythroblast enrichment
- Gastrointestinal disease diagnostics
- Blood group genotyping
- 3D cell culture model for drug development applications
- Equity valuation software
- Highly sensitive, low power gas sensors
- Enhanced cell lysis
- Sensitive particle based immunoassay platform
- Oral malodour diagnostic
- Platform technology for point of care diagnostics
If you are interested in any of these opportunities or working with UWE in development of new technologies, please contact us.